Mari Hayashida

408 total citations
32 papers, 283 citations indexed

About

Mari Hayashida is a scholar working on Surgery, Epidemiology and Gastroenterology. According to data from OpenAlex, Mari Hayashida has authored 32 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Epidemiology and 7 papers in Gastroenterology. Recurrent topics in Mari Hayashida's work include Microscopic Colitis (6 papers), Inflammatory Bowel Disease (6 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Mari Hayashida is often cited by papers focused on Microscopic Colitis (6 papers), Inflammatory Bowel Disease (6 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Mari Hayashida collaborates with scholars based in Japan and United States. Mari Hayashida's co-authors include Tadakazu Hisamatsu, Miki Miura, Daisuke Saito, Katsuya Kami, Yasuharu Oishi, Yoshinobu Ohira, Roland R. Roy, Ryo Ozaki, Shunichi Ogawa and Choitsu Sakamoto and has published in prestigious journals such as Journal of Applied Physiology, The American Journal of Gastroenterology and Pediatric Research.

In The Last Decade

Mari Hayashida

29 papers receiving 281 citations

Peers

Mari Hayashida
Ellen M. Reynolds United States
C. H. S. Cameron United Kingdom
John Wurzel United States
Ellen M. Reynolds United States
Mari Hayashida
Citations per year, relative to Mari Hayashida Mari Hayashida (= 1×) peers Ellen M. Reynolds

Countries citing papers authored by Mari Hayashida

Since Specialization
Citations

This map shows the geographic impact of Mari Hayashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Hayashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Hayashida more than expected).

Fields of papers citing papers by Mari Hayashida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari Hayashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Hayashida. The network helps show where Mari Hayashida may publish in the future.

Co-authorship network of co-authors of Mari Hayashida

This figure shows the co-authorship network connecting the top 25 collaborators of Mari Hayashida. A scholar is included among the top collaborators of Mari Hayashida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Hayashida. Mari Hayashida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fukui, Sho, Mitsumasa Kishimoto, Minoru Matsuura, et al.. (2025). Prevalence, characteristics, and screening of spondyloarthritis in Japanese patients with early inflammatory bowel diseases: a prospective multidisciplinary study. Journal of Gastroenterology. 61(1). 46–58.
2.
Ozaki, Ryo, Miki Miura, Mari Hayashida, et al.. (2023). Endoscopic Treatment of Colo-Colonic Intussusception in a Patient with Peutz-Jeghers Syndrome. Case Reports in Gastroenterology. 17(1). 339–345.
3.
Tanaka, Gen, et al.. (2022). Functional analysis of mutant SLCO2A1 transporters found in patients with chronic enteropathy associated with SLCO2A1. Journal of Gastroenterology and Hepatology. 37(9). 1776–1784. 2 indexed citations
4.
Ozaki, Ryo, Miki Miura, Daisuke Saito, et al.. (2021). Extent of disease affects the usefulness of fecal biomarkers in ulcerative colitis. BMC Gastroenterology. 21(1). 197–197. 15 indexed citations
5.
Saito, Daisuke, Minoru Matsuura, Ryo Ozaki, et al.. (2021). Clinical response of vedolizumab at week 6 predicted endoscopic remission at week 24 in ulcerative colitis. JGH Open. 5(9). 1056–1062. 8 indexed citations
6.
Saito, Daisuke, Miki Miura, Haruka Wada, et al.. (2020). Two cases in which tofacitinib effectively treated both ulcerative colitis and alopecia areata. Clinical Journal of Gastroenterology. 13(5). 788–793. 1 indexed citations
7.
Miura, Miki, Daisuke Saito, Mari Hayashida, et al.. (2019). Community-acquired fulminant colitis caused by binary toxin-producing Clostridium difficile in Japan. Clinical Journal of Gastroenterology. 12(4). 325–329. 2 indexed citations
8.
Saito, Daisuke, Ryo Ozaki, Miki Miura, et al.. (2019). MEFV Gene-Related Enterocolitis Account for Some Cases Diagnosed as Inflammatory Bowel Disease Unclassified. Digestion. 101(6). 785–793. 16 indexed citations
9.
Hisamatsu, Tadakazu, Daisuke Saito, & Mari Hayashida. (2019). [Review of small bowel disease (non-CD) -tumor, inflammation, and rare disease].. PubMed. 115(7). 575–586. 1 indexed citations
10.
Hayashida, Mari, et al.. (2019). Concept of a Logistics, Air Launch, and Recovery (LALAR) eVTOL Platform. AIAA Aviation 2019 Forum.
11.
Kobayashi, Taku, Ryo Ozaki, Shinji Okabayashi, et al.. (2018). Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients. Intestinal Research. 17(1). 87–93. 11 indexed citations
12.
Fujimori, Shunji, Koya Fukunaga, Atsushi Takahashi, et al.. (2018). Bactericidal/Permeability-Increasing Fold-Containing Family B Member 4 May Be Associated with NSAID-Induced Enteropathy. Digestive Diseases and Sciences. 64(2). 401–408. 2 indexed citations
13.
Saito, Daisuke, et al.. (2018). Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy. Intestinal Research. 16(2). 273–273. 26 indexed citations
14.
Tokunaga, K., Daisuke Saito, Miki Miura, et al.. (2017). Efficacy of the Dual Therapy With Vonoprazone and Amoxicillin as the Third Helicobacter pylori Eradication Regimen Based on Amoxicillin Susceptibility. The American Journal of Gastroenterology. 112. S669–S670. 2 indexed citations
15.
Wada, Haruka, Mari Hayashida, Miki Miura, et al.. (2017). A Caucasian American patient with celiac disease diagnosed in Japan and successfully treated with a gluten-free diet. Clinical Journal of Gastroenterology. 11(1). 23–28. 2 indexed citations
16.
Fujimori, Shunji, et al.. (2015). Celecoxib Monotherapy Maintained Small Intestinal Mucosa Better Compared With Loxoprofen Plus Lansoprazole Treatment. Journal of Clinical Gastroenterology. 50(3). 218–226. 13 indexed citations
17.
Kato, Yoshifumi, Atsuyuki Yamataka, Katsumi Miyahara, et al.. (2004). Recipient non-hematopoietic bone marrow cells in the intestinal graft after fetal small intestinal transplantation. Pediatric Surgery International. 20(1). 1–4. 3 indexed citations
18.
Tsuchiya, Masami, et al.. (2003). Ultrasound screening for renal and urinary tract anomalies in healthy infants. Pediatrics International. 45(5). 617–623. 24 indexed citations
19.
Kuramochi, Yukio, Ryuji Fukazawa, Makoto Migita, et al.. (2003). Cardiomyocyte Regeneration from Circulating Bone Marrow Cells in Mice. Pediatric Research. 54(3). 319–325. 28 indexed citations
20.
Asano, Tetsuo, et al.. (1998). Hypertrophic cranial pachymeningitis in a patient with aplastic anemia. Annals of Hematology. 77(6). 279–282. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026